Therapeutic drug monitoring of Antiinfectives in Critically Ill Patients

Therapeutic drug monitoring of Antiinfectives in Critically Ill Patients - TACIP

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030870

Enrollment

500

Registered

2022-12-19

Start date

2023-02-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intensive care unit patients treated with antiinfectives

Interventions

Group 1: Intensive care patients treated with antiinfectives and therapeutic drug monitoring (TDM)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with routine TDM of anti-infectives at LMU Klinikum or Krankenhaus Barmherzige Brüder München - Consent of the patient or the legal representive

Exclusion criteria

Exclusion criteria: Refusal of the patient or the legal representive

Design outcomes

Primary

Measure	Time frame
To determine which dosing strategies for antiinfectives are chosen by the treating physicians and to which concentrations these lead in the blood.	—

Secondary

Measure	Time frame
Further development of an existing mass spectrometric quantification method for other matrices (endotracheal aspiration, urine, dialysate, cerebrospinal fluid, bronchoalveolar lavage, blood from blood gas analysis syringes).	—

Countries

Germany

Contacts

Public ContactUwe Liebchen

LMU Klinikum

uwe.liebchen@med.uni-muenchen.de089-4400-81160

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026